Related Experiment Video
Updated: Aug 2, 2026
07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
New prospects for cardiovascular gene therapy
1Targeted Genetics Corp., 1100 Olive Way, Suite 100, Seattle, WA 98101, USA. lynchc@targen.com
Expert Opinion on Investigational Drugs
|July 2, 2005
Summary
Gene therapy for cardiovascular diseases faces challenges with current vectors. Adeno-associated virus (AAV) vectors show promise for improved in vivo gene delivery in the heart and vasculature.
Area of Science:
- Cardiovascular Research
- Gene Therapy
- Molecular Biology
Background:
- Cardiovascular gene therapy faces significant hurdles in effective in vivo gene delivery.
- Limitations include low transduction efficiency, transient transgene expression, and adverse immune/inflammatory reactions.
- These challenges have restricted the clinical application of cardiovascular gene therapy.
Purpose of the Study:
- To review recent advancements in gene delivery vectors for cardiovascular applications.
- To highlight the potential of adeno-associated virus (AAV) based vectors in cardiac and peripheral vasculature gene therapy.
- To discuss the improved prospects for in vivo cardiovascular gene therapy due to novel vector developments.
Main Methods:
- Review of recent scientific literature on gene delivery vectors.
- Focus on adeno-associated virus (AAV) vector development and application.
- Analysis of vector performance in cardiovascular (heart and peripheral vasculature) contexts.
Main Results:
- Adeno-associated virus (AAV) based vectors represent a significant advancement in cardiovascular gene therapy.
- These vectors demonstrate improved potential for in vivo gene delivery in the heart and peripheral vasculature.
- Recent developments address previous limitations like transduction efficiency and immune responses.
Conclusions:
- Adeno-associated virus (AAV) vectors offer new hope for effective in vivo cardiovascular gene therapy.
- Further development and application of AAV vectors are crucial for clinical translation.
- These vectors may overcome previous barriers to successful cardiovascular gene therapy.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...